8-Sep-2025 Lung cancer genetics study launches open-source data platform to research community 23andMe Research Institute Business Announcement
8-Sep-2025 Resistance mutations and the blood–brain barrier: Key challenges in targeted treatment of brain metastatic non-small cell lung cancer Compuscript Ltd Peer-Reviewed Publication
8-Sep-2025 How does chemotherapy disrupt circadian rhythms? Society for Neuroscience Peer-Reviewed Publication
8-Sep-2025 IU scientists reprogram cancer-protecting regulatory T cells to fight tumors Indiana University Peer-Reviewed Publication
8-Sep-2025 Cancer cells can use backup routes to fuel their growth Van Andel Research Institute Peer-Reviewed Publication
8-Sep-2025 Tarlatamab with anti-PD-L1 as first-line maintenance after chemo-immunotherapy for ES-SCLC demonstrates acceptable safety profile and unprecedented overall survival International Association for the Study of Lung Cancer Reports and Proceedings
8-Sep-2025 Moffitt develops first genetically engineered cancer model in naked mole rats H. Lee Moffitt Cancer Center & Research Institute Peer-Reviewed Publication
8-Sep-2025 First-ever clinical trial demonstrates safety, molecular readout and promise of pre- and post-surgery immunotherapy combination for patients with operable mesothelioma Johns Hopkins Medicine Peer-Reviewed Publication
8-Sep-2025 ‘Rogue’ DNA rings reveal earliest clues to deadly brain cancer’s growth Queen Mary University of London Peer-Reviewed Publication
8-Sep-2025 Clinical study deepens understanding of mesothelioma and opens the door to potential treatment options Georgetown University Medical Center Peer-Reviewed Publication